
DRUG EPS Estimates
Bright Minds Biosciences Inc.
$20.40
-$0.30(-1.45%)
30
Overall
60
Value
9
Tech
23
Quality
Market Cap
$203.26M
Volume
166.03K
52W Range
$17.40 - $123.75
Target Price
$115.71
DRUG EPS estimates: the consensus estimate for Bright Minds Biosciences Inc.'s current fiscal year is -$2.93 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
DRUG EPS Estimates
- EPS estimate, current quarter
- $-1.07
- EPS estimate, next quarter
- $-1.09
- EPS estimate, current year
- $-2.93
- EPS estimate, next year
- $-6.77
- EPS growth, 3-year
- +0.00%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.78 |
| 2024 | $-0.65 |
| 2023 | $-1.98 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DRUG | $20.40 | -1.4% | 166.03K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bright Minds Biosciences Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW